Candel Therapeutics (CADL) Research & Development (2020 - 2026)
Candel Therapeutics (CADL) posted Research & Development of $19.8 million for Q2 2026, up 183.2% from $6.99 million a year earlier.
Powered by 
Analysis
Candel Therapeutics (CADL) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Candel Therapeutics was $46.28 million, up 117.9% year-over-year; for FY2025, it was $30.5 million, up 57.9% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
- In prior years, Candel Therapeutics' Research & Development was $19.31 million in FY2024 (-21.2%), $24.51 million in FY2023 (+17.9%), $20.79 million in FY2022 (+37.0%) and $15.18 million in FY2021 (+73.4%).
- The Q2 2026 figure stands as the highest quarterly Research & Development in data going back to Q2 2020.
- On a year-over-year basis, Research & Development increased in four of the last seven quarters, with growth averaging 52.2%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2021, with growth of 190.4%; the weakest was Q4 2024, with a decline of 33.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Candel Therapeutics | 851.76 Mn | 851.76 Mn | - | 19.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.80 Mn |
| Dec 31, 2025 | 11.03 Mn |
| Sep 30, 2025 | 8.46 Mn |
| Jun 30, 2025 | 6.99 Mn |
| Mar 31, 2025 | 4.02 Mn |
| Dec 31, 2024 | 4.82 Mn |
| Sep 30, 2024 | 5.42 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 4.10 Mn |
| Dec 31, 2023 | 7.26 Mn |
| Sep 30, 2023 | 5.85 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 4.97 Mn |
| Sep 30, 2022 | 5.38 Mn |
| Jun 30, 2022 | 5.02 Mn |
| Mar 31, 2022 | 5.42 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Sep 30, 2021 | 5.27 Mn |
| Jun 30, 2021 | 3.29 Mn |
API Access
Candel Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();